73 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline that will be synergistic with its
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline of tumor microenvironment agents
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
5 Feb 24
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
8:09am
and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
Coherus BioSciences
Coherus is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative … immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline that will be synergistic with its proven commercial
8-K
EX-99.1
ezd3bawwxq
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K
EX-99.1
chtw 47m6f
27 Oct 23
Regulation FD Disclosure
4:19pm
424B5
oouj51wic1 v9q
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
yt7b532c04 kq
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am
8-K
EX-99.1
94w ybq8c5jo3fho
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
yesj54m
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
nursdkui
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
3mf jpmnjmz8bysg
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
tnzgb30i
16 Jun 23
Business combination disclosure
5:14pm
425
wemfre8k yr3y
16 Jun 23
Business combination disclosure
5:12pm
425
gzcvw1 txg
16 Jun 23
Business combination disclosure
5:11pm
425
8ty8f5qpm 1lp
16 Jun 23
Business combination disclosure
8:08am
425
4xfuo8y5
16 Jun 23
Business combination disclosure
7:09am